Search Results - Matthew Zibelman

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis by Matthew Zibelman, Anthony J. Olszanski, Natasha Pollak, Marc-Elie Nader, Jeffrey N. Myers, Paul W. Gidley

    Published in Journal for ImmunoTherapy of Cancer (2017-08-01)
    Get full text
    Article


  2. 2

    665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress by Neal Shore, Robert Dreicer, Matthew Zibelman, Mark N Stein, Ralph J Hauke, Russell Pachynski, Bethan Jones, Jessica Hawley, Charlotte Davis, Katie Anderson, Antonella Vardeu, Margaret A Marshall, Vicky Wheeler, Sarah Sebastian, Kevin Kayvan Zarrabi, Brian Miles, Jennifer Bendall

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  3. 3

    A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors by Matthew Zibelman, Alexander W. MacFarlane, Kimberly Costello, Thomas McGowan, John O’Neill, Rutika Kokate, Hossein Borghaei, Crystal S. Denlinger, Efrat Dotan, Daniel M. Geynisman, Angela Jain, Lainie Martin, Elias Obeid, Karthik Devarajan, Karen Ruth, R. Katherine Alpaugh, Essel Al-Saleem Dulaimi, Edna Cukierman, Margret Einarson, Kerry S. Campbell, Elizabeth R. Plimack

    Published in Nature Communications (2023-07-01)
    Get full text
    Article


  4. 4

    Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma by Tian Zhang, Carl Morrison, Sarabjot Pabla, Jason Zhu, Matthew Zibelman, Shannon McCall, Sean T Glenn, Saby George, Yong Hee Lee, Landon C Brown, Chester Kao, Matthew K Labriola, Rajan T Gupta, Daniel J George, Laura J Tafe, Farshid Dayyani, Kunal Desai, Moshe C Ornstein, Emily Kinsey, Jennifer Tran, Konstantin H Dragnev, Mary K Nesline

    Published in Journal for ImmunoTherapy of Cancer (2022-10-01)
    Get full text
    Article


  5. 5

    Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat... by Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman

    Published in Journal for ImmunoTherapy of Cancer (2023-01-01)
    Get full text
    Article


  6. 6

    Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid ca... by Yan Liu, Matthew Zibelman, Timothy Chan, Justin Guinney, Douglas Adkins, Ezra E W Cohen, Michelle M Stein, Halla Nimeiri, Sandip P Patel, Alia D Zander, Rossin Erbe, Ailin Jin, Sayantoni Mukhopadhyay, Ben Terdich, Mario G Rosasco, Nirali Patel, Chithra Sangli, Timothy Taxter, Seung Won Hyun, Brett M Mahon, A Kate Sasser, Michelle A Ting-Lin, Kyle A Beauchamp

    Published in Journal for ImmunoTherapy of Cancer (2025-05-01)
    Get full text
    Article


Search Tools: